Stay updated on Immunotherapy in Resectable Head & Neck SCC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    New user-facing sections have been added to guide potential participants (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label formatting has been updated. A recruitment status update ('No longer looking for participants') and a page revision (Revision: v3.6.0) were also applied.
    Difference
    0.4%
    Check dated 2026-06-14T05:18:19.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page metadata now shows revision v3.5.5, replacing the previous v3.5.4. This reflects a minor update to the page rather than any change to study content or results.
    Difference
    0.0%
    Check dated 2026-06-07T01:39:25.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    No additions or deletions were provided in the change data, so there is nothing to interpret.
    Difference
    0.0%
    Check dated 2026-05-30T21:57:14.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    There are no additions or deletions to evaluate. The page content remains unchanged.
    Difference
    0.0%
    Check dated 2026-05-23T12:38:26.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.5.4, indicating an editorial update to the page's content or metadata. This reflects a version bump rather than a substantive change to the study details.
    Difference
    0.0%
    Check dated 2026-05-16T09:24:39.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Added TP53-focused outcome analyses for Cohort 1, specifying EFS and OS differences by TP53 status. This replaces the prior broader presence/absence approach with a gene-specific analysis in the first cohort.
    Difference
    0.3%
    Check dated 2026-05-09T03:20:18.000Z thumbnail image

Stay in the know with updates to Immunotherapy in Resectable Head & Neck SCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy in Resectable Head & Neck SCC Clinical Trial page.